Neumora Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
NMRA
CUSIP
640979100
Type
Equity
Class
COM
Num filings
104
Total reported value, excl. options
$714 M
Manager Report Date Value ($000) Shares Option Type